VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PDEXPro-Dex, Inc.
$64.37$206M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPDEXPrice Target
PDEX logo

Pro-Dex, Inc. (PDEX) Price Target Analysis

Analyst Rating: Buy
Based on 1 analysts

No Target Data

PDEX trades at Wall Street's consensus target of —.

Current Price$64.37
Average Target—
Low—
Median—
High—

Analyst Target Range

Forward P/E16.3x
(Fair)
PEG Ratio1.34
(Fair)
Implied Growth+7.3%
(Low)
Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$64.37
Consensus—
High—
Low—

Consensus Scenario Assumptions

The base valuation assumes PDEX achieves its forward estimates and maintains a stable P/E multiple of 16.3x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 1 published analyst recommendations for PDEX

1/1 analysts are bullish
+50
BearishBullish
Weighted analyst sentiment score based on 1 ratings
ConsensusBuy
Coverage1 Analysts
Net Score+50
Bull / Bear100% / 0%
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%
Recommendation Mix100% Buy · 0% Hold · 0% Sell
Buy (1)Hold (0)Sell (0)

PDEX Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, Pro-Dex, Inc. (PDEX) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $206M.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, PDEX trades at a trailing P/E of 24.1x and forward P/E of 16.3x. The forward PEG ratio of 1.34 indicates reasonable valuation for growth. Analysts expect EPS to grow +7.3% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $97.44, with bear and bull scenarios of $61.39 and $128.39 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+43.5%
Industry Consensus
Avg Forward P/E
123.9x
(High Premium)
Peers with Coverage
8 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
NSYS logo
NSYSNortech Systems Incorporated
$49M$17.49—————
LIQT logo
LIQTLiqTech International, Inc.
$9M$0.90—————
ATRC logo
ATRCAtriCure, Inc.
$1.5B$28.80$51.33
+78.2%
Buy768.0x19
MMSI logo
MMSIMerit Medical Systems, Inc.
$4.0B$67.22$94.20
+40.1%
Buy16.5x14
NVCR logo
NVCRNovoCure Limited
$1.6B$14.28$33.00
+131.1%
Buy—15
OSIS logo
OSISOSI Systems, Inc.
$3.7B$222.78$310.00
+39.2%
Buy21.4x18
SYK logo
SYKStryker Corporation
$117.9B$307.80$387.46
+25.9%
Buy20.5x51
ZBH logo
ZBHZimmer Biomet Holdings, Inc.
$17.2B$87.97$96.33
+9.5%
Hold10.4x42
MDT logo
MDTMedtronic plc
$101.9B$79.34$95.80
+20.7%
Buy13.3x51
HOLX logo
HOLXHologic, Inc.
$17.0B$76.01$78.69
+3.5%
Hold17.2x42

PDEX — Frequently Asked Questions

Quick answers to the most common questions about buying PDEX stock.

What is the PDEX stock price target for 2026?

The consensus price target for PDEX is $N/A, close to the current price of $64.37 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.

Is PDEX a buy, sell, or hold?

PDEX has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is PDEX stock overvalued or undervalued?

With a forward P/E of 16.3376x, PDEX trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.

How high can PDEX stock go?

The most bullish Wall Street analyst has a price target of $N/A for PDEX, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $128 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover PDEX stock?

PDEX is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the PDEX stock forecast?

The 12-month PDEX stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $97, with bear/bull scenarios of $61/$128.

What is PDEX's fair value based on fundamentals?

Our quantitative valuation model calculates PDEX's fair value at $97 (base case), with a bear case of $61 and bull case of $128. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.

What is PDEX's forward P/E ratio?

PDEX trades at a forward P/E ratio of 16.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy PDEX stock?

PDEX appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do PDEX price targets vary so much?

PDEX analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $61-$128 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare